Literature DB >> 32222091

Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront….

Sabrina Buoro1, Fabiano Di Marco2, Marco Rizzi3, Fabrizio Fabretti4, Ferdinando Luca Lorini5, Simonetta Cesa6, Stefano Fagiuoli7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32222091     DOI： 10.1111/ijlh.13207

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN： 1751-5521            Impact factor:   2.877


× No keyword cloud information.
  17 in total

Review 1.  COVID-19-another influential event impacts on laboratory medicine management.

Authors:  YunTao Luo; JingHua Wang; MinMin Zhang; QingZhong Wang; Rong Chen; XueLiang Wang; HuaLiang Wang
Journal:  J Clin Lab Anal       Date:  2021-05-25       Impact factor: 2.352

2.  Morphological anomalies of circulating blood cells in COVID-19.

Authors:  Gina Zini; Silvia Bellesi; Francesco Ramundo; Giuseppe d'Onofrio
Journal:  Am J Hematol       Date:  2020-04-22       Impact factor: 10.047

3.  SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat.

Authors:  Peter M Kreuzer; Thomas C Baghai; Rainer Rupprecht; Markus Wittmann; Dagmar Steffling; Michael Ziereis; Marc Zowe; Helmut Hausner; Berthold Langguth
Journal:  Front Psychiatry       Date:  2020-06-11       Impact factor: 4.157

4.  COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.

Authors:  Andrea Carugno; Daniele Mario Gambini; Francesca Raponi; Pamela Vezzoli; Andrea Gustavo C Locatelli; Marco Di Mercurio; Elisa Robustelli Test; Paolo Sena
Journal:  J Am Acad Dermatol       Date:  2020-05-06       Impact factor: 11.527

5.  Addressing a national crisis: the spine hospital and department's response to the COVID-19 pandemic in New York City.

Authors:  J M Lombardi; T Bottiglieri; N Desai; K D Riew; V Boddapati; M Weller; C Bourgois; S McChrystal; R A Lehman
Journal:  Spine J       Date:  2020-05-31       Impact factor: 4.166

6.  Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo, Italy.

Authors:  A Carugno; P Sena; F Raponi; E Robustelli Test; P Vezzoli
Journal:  Br J Dermatol       Date:  2020-06-28       Impact factor: 11.113

Review 7.  COVID-19 and the clinical hematology laboratory.

Authors:  John L Frater; Gina Zini; Giuseppe d'Onofrio; Heesun J Rogers
Journal:  Int J Lab Hematol       Date:  2020-06       Impact factor: 3.450

8.  In Reply: The Coronavirus Disease 2019 Global Pandemic: A Neurosurgical Treatment Algorithm.

Authors:  Alberto Balestrino; Pietro Fiaschi; Ilaria Melloni; Niccolò Riccardi; Alessandro Prior; Gianluigi Zona
Journal:  Neurosurgery       Date:  2020-08-01       Impact factor: 4.654

9.  Treatment of Proximal Femoral Fragility Fractures in Patients with COVID-19 During the SARS-CoV-2 Outbreak in Northern Italy.

Authors:  Francesco Catellani; Andrea Coscione; Riccardo D'Ambrosi; Luca Usai; Claudio Roscitano; Gennaro Fiorentino
Journal:  J Bone Joint Surg Am       Date:  2020-06-17       Impact factor: 6.558

10.  No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Authors:  A Carugno; F Raponi; A G Locatelli; P Vezzoli; D M Gambini; M Di Mercurio; E Robustelli Test; P Sena
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-15       Impact factor: 9.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.